Evidence map›Paper›PMID 36217202›Full record

ArticleJournal of experimental & clinical cancer research : CR2022

STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth.

Hongwu Li, Ping Liu, Dapeng Li, Zixi Wang, Zhao Ding, Meng Zhou, Xu Chen, Manli Miao, Junli Ding, Wei Lin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. ALKBH5 aggravates scarring after glaucoma surgery via mCell death and differentiation · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hongwu Li *Department of Otorhinolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Ping Liu *Department of Otorhinolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Dapeng Li *Department of Otorhinolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Zixi Wang *Department of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Zhao DingDepartment of Otorhinolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Meng ZhouDepartment of Pharmacy, Genertec Universal Medical Maanshan Shiqiye Hospital, Maanshan, 243000, Anhui Province, China.
Xu ChenDepartment of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Manli MiaoDepartment of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Junli DingDepartment of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Wei LinDepartment of Stomatology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China. linwei@ahmu.edu.cn.
Yehai LiuDepartment of Otorhinolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China. liuyehai@ahmu.edu.cn.
Xiaojun ZhaDepartment of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China. zhaxiaojunpumc@gmail.com.ORCID http://orcid.org/0000-0003-4006-0748
Anhui Medical University · CN

Funding

2020 Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University 2020xkjT027Anhui Provincial Natural Science Foundation 1808085MH261Anhui Provincial Natural Science Foundation 2208085MH239Discipline Construction Project of the First Affiliated Hospital of Anhui Medical University No. 4245Natural Science Foundation of Anhui Medical University 2020xkj153Natural Science Foundation of China 81372475Natural Science Foundation of China 82171127Natural Science Foundation of Universities of Anhui Province KJ2019A0219
6 · The paper itself

Abstract

backgroundAberrantly activated mammalian target of rapamycin complex 1 (mTORC1) plays a vital role in tumor angiogenesis, but its precise mechanisms are still unclear.

methodsMicro-RNA-130b-3p (miR-130b-3p) expression in mTORC1-activated and control cells was examined by quantitative real-time PCR (qRT-PCR). MiR-130b-3p levels and their correlation with mTORC1 activity were evaluated by analyzing publicly available databases and in-house head and neck squamous cell carcinoma (HNSCC) tissues. The role of miR-130b-3p in mTORC1-mediated angiogenesis and tumor growth was examined using tube formation assay, chicken chorioallantoic membrane assay, cell line - derived xenograft models, and an HNSCC patient-derived xenograft (PDX) model. The regulatory mechanisms among signal transducer and activator of transcription 3 (STAT3), miR-130b-3p, and muscleblind-like protein 1 (MBNL1) were investigated via bioinformatics analyses, qRT-PCR, western blot, RNA immunoprecipitation, immunofluorescence, luciferase reporter assay, and chromatin immunoprecipitation assay.

resultsElevated miR-130b-3p enhanced the angiogenic and tumorigenic abilities of mTORC1-activated cells both in vitro and in vivo. STAT3, a downstream effector of mTORC1, transactivated miR-130b-3p by direct binding promoter of the miR-130b gene. MBNL1 was identified as a direct target of miR-130b-3p. MBNL1 depletion rescued the compromised angiogenesis and tumor growth caused by miR-130b-3p inhibition. MiR-130b-3p levels were significantly upregulated and positively correlated with mTORC1 signaling in multiple cancers. MiR-130b-3p inhibition attenuated tumor angiogenesis and growth in an HNSCC PDX model. MBNL1 feedback inhibited STAT3 activation in mTORC1-activated cells.

conclusionsThe STAT3/miR-130b-3p/MBNL1 feedback loop plays a vital role in mTORC1-mediated angiogenesis and tumor progression. This pathway could be targeted for therapeutic intervention of mTORC1-related cancers.

Indexed as

Head and Neck NeoplasmsMicroRNAsRNA-Binding ProteinsSquamous Cell Carcinoma of Head and NeckSTAT3 Transcription FactorCell Line, TumorCell ProliferationFeedbackGene Expression Regulation, NeoplasticHumansMechanistic Target of Rapamycin Complex 1Neovascularization, PathologicTOR Serine-Threonine KinasesMBNL1 protein, humanMechanistic Target of Rapamycin Complex 1MicroRNAsMIRN130 microRNA, humanRNA-Binding ProteinsSTAT3 protein, humanSTAT3 Transcription FactorTOR Serine-Threonine KinasesAngiogenesisMBNL1miR-130b-3pmTORSTAT3Tumor growth

Identifiers

PMID36217202
PMCPMC9552455
OpenAlexW4304140153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.